Bone Densitometer Market Outlook:
Bone Densitometer Market size was over USD 297.43 million in 2025 and is poised to exceed USD 461.9 million by 2035, growing at over 4.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of bone densitometer is evaluated at USD 309.48 million.
The major factor for the expansion of the global bone densitometer is the rising cases of bone disorders and related diseases including muscular dystrophy, and Duchene muscular dystrophy among the global population. Furthermore, if these diseases are not treated with effectiveness, they worsen over time and can lead to degenerative disease and orthopedic limitation which generates the need for bone densitometer. The National Library of Medicine published a report in 2018 that calculated the prevalence of osteoporosis to be more than 200 million people across the world. It also has been calculated that the occurrence of osteoporosis in women around the world is more than 23% and in men around the world was found to be almost 11%.
The growth of the bone densitometer market is attributed to growing cases of osteoporosis among the population, the surge in the incidence of accidents and traumas, and the development of new bone densitometer products by the major key players operating in the market. Furthermore, the increase in the number of product approvals by regulatory bodies is anticipated to provide remunerative opportunities for the expansion of the global bone densitometer during the forecast period.
Key Bone Densitometer Market Insights Summary:
Regional Highlights:
- North America is projected to command over 35% revenue share of the bone densitometer market by 2035, fueled by the expanding healthcare industry and rising cases of amputations linked to bone fractures and related disorders
- Europe is anticipated to capture more than 24% share by 2035, propelled by the growing preference for minimally invasive medical procedures and the upsurge in manufacturing of advanced medical tools and assistive equipment
Segment Insights:
- The osteoporosis & osteopenia segment is poised to account for over 32% share of the bone densitometer market by 2035, driven by rising cases of osteoporosis and osteopenia amid increasing adoption of sedentary lifestyles and a rapidly expanding geriatric population
- The Hospital segment is expected to hold more than 46% share by 2035, attributed to the growing geriatric population requiring continuous care alongside rising healthcare expenditure and expanding government investments in hospital infrastructure
Key Growth Trends:
- Growing Prevalence of Musculoskeletal Diseases
- Rapid Growth of the Orthopedic Devices Industry
Major Challenges:
- High Cost of Bone Densitometer
- Requirement of High Initial Investments
Key Players: Aetna Inc., Pfizer Inc., Cadila Pharmaceuticals Limited, R N Laboratories Pvt Ltd, Neoss Limited, Basic Pharma Lifesciences Pvt Ltd, Dawood and Tanner, Prachi Pharmaceuticals Private Limited, Geistlich Pharma AG., Healthy Life Pharma Private Limited.
Global Bone Densitometer Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 297.43 million
- 2026 Market Size: USD 309.48 million
- Projected Market Size: USD 461.9 million by 2035
- Growth Forecasts: 4.5% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (35% Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, Japan, China, United Kingdom
- Emerging Countries: China, India, Japan, South Korea, Australia
Last updated on : 25 February, 2026
Bone Densitometer Market - Growth Drivers and Challenges
Growth Drivers
-
Growing Prevalence of Musculoskeletal Diseases - Musculoskeletal diseases are a group of diseases that usually affects the joints, bones, and muscles, and aid the development of other bone diseases and their related illnesses. Treatment of such musculoskeletal conditions requires bone densitometer for an effective healing process of bones. As per the statistics shared by the World Health Organization (WHO) in 2022, approximately 1.71 billion people are affected by musculoskeletal conditions all over the world.
-
Rapid Growth of the Orthopedic Devices Industry –This expansion of orthopedic devices is anticipated to generate favorable opportunities for an increase in the utilization rate of bone densitometer in treating bone diseases. For instance, the orthopedic device industry was expected to reach a total value of USD 45 billion by 2022.
- Rapid Escalation in Number of Bone Fractures – For instance, in 2019, there were more than 175 million cases of fractures and approximately 450 million cases of acute or long-term symptoms of a fracture.
- High Focus on Developing the Medical Devices Sector - The data revealed by the India Brand Equity Foundation (IBEF) stated that in FY20, the foreign investments in the Indian medical devices sector increased to USD 301 million from USD 151 million in FY19, which indicates a 98% increment.
Challenges
-
High Cost of Bone Densitometer – Dual-energy X-ray Absorptiometry (DEXA) is one of the most common methods of bone densitometer for detecting bone mineral density. However, the cost of DEXA scanners is very much high owing to the integration of technologically advanced features and programs.
-
Requirement of High Initial Investments
- Unavailability of Skilled Workforce for Utilization of Advanced Devices
Bone Densitometer Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
4.5% |
|
Base Year Market Size (2025) |
USD 297.43 million |
|
Forecast Year Market Size (2035) |
USD 461.9 million |
|
Regional Scope |
|
Bone Densitometer Market Segmentation:
Application Segment Analysis
The osteoporosis & osteopenia segment is poised to account for bone densitometer market share of more than 32% by the end of 2035, due to rising cases of osteoporosis & osteopenia owing to the adoption of a sedentary lifestyle. Also, the burgeoning geriatric population who are more prone to osteoporosis & osteopenia is considered to positively contribute towards segment growth. As per the data provided by the World Health Organization (WHO), the share of the population of age 60 or above in the world increased from 1 billion to 1.4 billion in 2022 and is projected to double by 2050 reaching around 2.1 billion.
End-User Segment Analysis
Hospital segment is expected to hold bone densitometer market share of over 46% by the end of 2035, attributed to the burgeoning of the geriatric population with a disability who requires full-time assistance and generally admits into hospitals. Moreover, the increasing investment in hospitals by governments of different nations, along with the rising healthcare expenditure, and the availability of the dedicated orthopedic section in the hospital. It was noted that spending on health care in the United States increased 2.7 percent in 2021 to USD 4.3 trillion, or USD 12,914 per person. Total expenditure on healthcare accounted for more than 18 percent of the region’s GDP.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Technology |
|
|
Scan |
|
|
Application |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Bone Densitometer Market - Regional Analysis
North American Market Insights
In bone densitometer market, North America region is estimated to hold over 35% revenue share by the end of 2035. The presence of the blooming healthcare industry and the rising cases of amputations owing to numerous reasons including bone fractures and various bone illnesses. It is estimated that in the United States, every year, nearly 170,000 amputation procedures take place and around 3.5 million people are estimated to with limb loss by the year 2050.
European Market Insights
In bone densitometer market, Europe region is anticipated to account for revenue share of more than 24% by the end of 2035, on the back of increasing preference for minimally invasive medical procedures. An up-surged manufacturing process of novel tools and other assistive equipment can also be observed in the region which is anticipated to create a positive outlook for market growth.
Key Bone Densitometer Market Players:
- AMPall
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eurotec Medical Systems s.r.l.
- Medonica Co., Ltd.
- Scanflex Healthcare AB
- BeamMed Ltd.
- Swissray Global Healthcare Holding Ltd.
- Diagnostic Medical Systems Group
- OSI Systems, Inc.
- Hologic, Inc.
- GE Healthcare
- Echolight S.p.a
Recent Developments
- Hologic, Inc. has partnered with DEXA+ to distribute the company’s Horizon DXA system for body composition measurement. This partnership is expected to expand Hologic, Inc.’s profile in body composition assessment.
- Echolight S.p.a has entered into a joint co-marketing agreement with Aurora Spine Corporation for assessing the patient’s bone mineral density (BMD) and the quality of bone microarchitecture independent of BMD.
- Report ID: 3838
- Published Date: Feb 25, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Bone Densitometer Market Report Scope
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
